RSS-Feed abonnieren

DOI: 10.1055/a-2695-1832
Colorectal mucosal exposure area assessment based on artificial intelligence: a multi-center, prospective, observational study
Gefördert durch: Key Research and Development Program of Hubei Province 2023BCB153
Gefördert durch: Project of Hubei Provincial Clinical Research Center for Digestive Disease Minimally Invasive Incision 2024CCB007
Gefördert durch: National Key Research and Development Program of China 2022YFC2505100
Gefördert durch: National Natural Science Foundation of China-Youth Science Fund 82202257,82303949
Gefördert durch: College-enterprise Deepening Reform Project of Wuhan University Clinical Trial: Registration number (trial ID): ChiCTR2400090298, Trial registry: Chinese Clinical Trial Registry (http://www.chictr.org/), Type of Study: Multi-center, Prospective, Observational Study

Background: This study proposed a new quality control indicator, cumulative colorectal mucosal exposure area (CCMEA) for colonoscopy to assess mucosal exposure, constructed CCMEA system based on deep learning. and validated the indicator in a multi-center prospective observational study. Methods: The CCMEA system worked based on ResNet50 and UNet++. Determine the CCMEA threshold for qualified colonoscopies based on international colonoscopy quality criteria, the 25% adenoma detection rate (ADR). A multi-center prospective observational study was conducted to evaluate the system and threshold in clinical practice. Based on the threshold, patients were divided into the qualified and unqualified group, with ADR and other lesion detection rates were compared between the two groups. Results: A total of 510 participants underwent colonoscopy were evaluated, with grouping into qualified (n=270) and unqualified (n=240) groups based on the CCMEA qualification threshold of 2000.. ADR was 39.53 percentage points higher in the qualified group than in the unqualified group (53.70% vs 14.17%, aOR=7.97, 95%CI 4.97-12.80, p<0.001), especially for lesions ≤5 mm (42.22% vs. 10.00%, aOR=6.85, 95%CI 4.09-11.46, p<0.001). The qualified group also had a significantly greater polyp detection rate (89.63% vs. 40.00%, aOR=13.05, 95%CI 7.81-21.82, p<0.001) and higher mean number of both adenomas (1.00 vs 0.17, aIRR=5.94, 95%CI 4.32-8.36, p<0.001) and polyps (5.79 vs 1.32, aIRR=3.99, 95%CI 3.52-4.52, p<0.001). Conclusions: The CCMEA qualified group, based on a CCMEA threshold of 2000, shows higher ADR than the unqualified group, indicating CCMEA can be a promising colonoscopy quality indicator.
Publikationsverlauf
Eingereicht: 24. März 2025
Angenommen nach Revision: 29. August 2025
Accepted Manuscript online:
03. September 2025
© . The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany